A federal judge will soon determine whether Pfizer can pay Medicare patients’ out-of-pocket expenses for one of its heart medications that is priced at $225,000 per year.
Crony Capitalism Alert: Here Comes Pfizer’s Massive Raid On Medicare
Not a Contra Corner Subscriber?
